Spasmolit Tablet (Trospium Chloride)

Adult dose

Adults: The usual dose is 20 mg of trospium chloride per dose, taken orally twice daily with water, without chewing. The dose may be adjusted according to age and symptoms.

This medication should not be used in patients with certain conditions. For example, it should not be administered to patients with closed-angle glaucoma, urinary retention, or those with mechanical bowel obstruction. Additionally, caution is needed in patients with irregular heart rhythms, myasthenia gravis, or megacolon. As this medication contains lactose, those with lactose intolerance or genetic carbohydrate metabolism issues should refrain from use. Taking this medication may reduce or redden skin sweating, cause glaucoma or vision impairment, and can lead to dry mouth and rapid heart rate symptoms. There may also be difficulties in urination. As vision control problems may occur, it is advisable to avoid driving or operating hazardous machinery while on this medication. This medication may interact with other drugs, and side effects may be exacerbated when taken with certain antidepressants, antihistamines, or heart medications. Women who are pregnant or breastfeeding should avoid taking this medication unless absolutely necessary and should do so under strict medical supervision. In case of an overdose, symptoms such as vision impairment, increased heart rate, dry mouth, and skin redness may occur. If these symptoms occur, seek medical attention immediately, and specific medications can alleviate symptoms.

• Anticholinergic action
• sweat suppression
• erythema
• closed-angle glaucoma
• dysregulation
• thirst
• tachycardia
• urinary difficulty
• visual accommodation disturbances
• dry mouth

Store this medication in a tightly sealed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1 degree and 30 degrees Celsius.

Appearance

Pale yellowish-brown tablet

Package unit

30, 100 tablets/bottle